nVerses Capital’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-20,798
Closed -$148K – 33
2026
Q2
$148K Buy
+20,798
New +$149K 0.23% 221
2024
Q4
– Sell
-400
Closed -$3.56K – 87
2024
Q3
$3.56K Buy
+400
New +$3.43K ﹤0.01% 944

Other funds holding AURA

nVerses Capital's AURA Position: Q3 2026 in Review

nVerses Capital sold out of Aura Biosciences (AURA) in Q3 2026, closing a stake of 20,798 shares — an estimated $148K sold.

nVerses Capital first reported a position in AURA in Q3 2024 and held it in 2 quarters. The position peaked at $148K in Q2 2026. 154 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • nVerses Capital reported no remaining Aura Biosciences position as of Q3 2026 after selling out during the quarter.
  • nVerses Capital sold 20,798 Aura Biosciences shares in Q3 2026, an estimated $148K.
  • nVerses Capital first reported a position in Aura Biosciences in Q3 2024 and held it in 2 quarters.
  • nVerses Capital's Aura Biosciences position peaked at $148K in Q2 2026.
  • 154 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on nVerses Capital's 13F filing for Q3 2026.